Delivering Innovative Therapeutic Options for Gastrointestinal Diseases and Women’s Health

Sebela Pharmaceuticals® is a U.S. pharmaceutical
company with a market-leading position in Gastroenterology
and a focus on innovation in Women's Health.

MISSION, VISION, AND VALUES >

The First Low-Dose Hormone-Free Intra-Uterine Device (IUD) in the U.S. in Over 40 Years

READ THE PRESS RELEASE >

Sebela Women's Health Announces Publication of Phase 3 Pivotal Study Results for the Investigational Copper 175 mm2 Intrauterine Device (IUD) in Contraception

READ THE PRESS RELEASE >
MORE NEWS AND EVENTS >
RESEARCH AND DEVELOPMENT

RESEARCH AND DEVELOPMENT

Sebela Pharmaceuticals’ development strategy aims to advance the company’s mission of improving patients’ lives with innovative pharmaceuticals. Through our affiliate Braintree, Sebela is leading the way in Gastroenterology.

LEARN MORE >

Corporate Partnership

Braintree, a part of Sebela Pharmaceuticals, is a proud supporter of the following organizations:

Tablets
Tablets
Tablets
Tablets

DISCOVER SEBELA WOMEN’S HEALTH

Sebela Women’s Health seeks to enrich the health and well-being of women – and the lives of those who care about them. We're developing next-generation therapeutics with innovative features that help address the needs of women today.

DISCOVER MORE ABOUT US >
DISCOVER SEBELA WOMEN'S HEALTH